Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Oakdale › NPI 1346381415
Transport

Oak Valley Hospital District

Oak Valley Hospital District was paid $23.63M by Medicaid between Jan 2018 and Dec 2024, across 254 billing codes. Its largest line is 0450, Emergency room services — 16% of everything it billed.

33Billing provider infoOAK VALLEY HOSPITAL DISTRICT
OAKDALE, CA 95361
33aNPI1346381415assigned 02/09/2007
33bProvider typeLand Ambulance
28Total paid$23.63M
24GClaims803,068
24DCodes billed254
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Land Ambulance providers in California

Rank by total paid#11 of 177
Median peer was paid$1.79M
This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018146,911$3.76M
2019126,083$3.40M
202099,945$2.88M
2021107,161$3.31M
2022110,730$3.41M
2023109,448$3.28M
2024incomplete102,790$3.58M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 16% 71,309 63,317 $3.74M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 15% 107,669 93,957 $3.55M
A0427 Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 7.6% 11,017 9,575 $1.79M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6.5% 31,027 28,310 $1.53M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 4.6% 47,017 41,732 $1.09M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.7% 2,603 2,497 $638K
A0425 Ground mileage, per statute mile 2.6% 13,021 11,201 $624K
80053 Comprehensive metabolic panel 1.9% 28,824 26,590 $440K
70450 Computed tomography, head or brain; without contrast material 1.5% 3,043 2,934 $358K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.5% 5,576 5,005 $347K
59425 1.4% 4,489 2,989 $326K
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient 1.4% 6,101 4,508 $323K
242 more codes
J3490 Unclassified drugs 1.3% 15,064 $306K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.1% 3,814 $267K
77067 Screening mammography, bilateral, including computer-aided detection 1.1% 2,643 $265K
Z7502 1.1% 7,521 $264K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.1% 9,898 $262K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 1,872 $260K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.1% 5,653 $253K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.0% 27,739 $247K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.0% 8,702 $241K
Q3014 Telehealth originating site facility fee <1% 7,869 $213K
96375 Therapeutic injection; each additional sequential IV push <1% 3,904 $176K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 3,231 $175K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 2,526 $172K
97139 <1% 8,387 $170K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,583 $169K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 11,323 $160K
71046 Radiologic examination, chest; 2 views <1% 6,366 $150K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 3,140 $145K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,813 $145K
84443 Thyroid stimulating hormone (TSH) <1% 6,567 $139K
99203 Doctor's office visit, new patient (routine) <1% 1,966 $136K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,112 $134K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,182 $131K
92552 <1% 6,205 $123K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,572 $120K
80061 Lipid panel <1% 7,209 $109K
76830 Ultrasound, transvaginal <1% 1,715 $106K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,346 $104K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,507 $103K
96361 Intravenous infusion, hydration; each additional hour <1% 3,636 $101K
H1001 Prenatal care, at-risk enhanced service; antepartum management <1% 1,240 $100K
90715 <1% 3,369 $99K
0270 <1% 11,239 $98K
83036 Hemoglobin; glycosylated (A1C) <1% 7,183 $92K
76801 <1% 1,376 $90K
71045 Radiologic examination, chest; single view <1% 6,254 $84K
0360 <1% 583 $80K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 1,875 $73K
99215 Doctor's office visit, returning patient (complex) <1% 900 $73K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,835 $72K
87631 <1% 973 $70K
83880 <1% 2,365 $66K
81001 <1% 15,579 $65K
85730 <1% 9,356 $65K
83690 <1% 8,217 $62K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,881 $61K
84484 <1% 4,951 $61K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,331 $56K
73562 <1% 2,132 $56K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,196 $55K
81025 <1% 11,002 $54K
90686 <1% 2,465 $54K
A0429 Emergency ambulance ride, basic life support <1% 371 $51K
76641 <1% 717 $50K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 400 $50K
73630 <1% 1,778 $47K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 558 $47K
85610 <1% 10,022 $46K
82150 <1% 6,380 $46K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 1,098 $45K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 629 $44K
80305 <1% 2,878 $41K
99283 Emergency room visit (moderate) <1% 985 $41K
73030 <1% 1,517 $39K
90656 <1% 2,324 $37K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 643 $37K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,163 $36K
81003 <1% 15,081 $36K
73610 <1% 1,173 $35K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 543 $32K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,507 $30K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,606 $30K
83874 <1% 2,590 $29K
72110 <1% 717 $29K
87186 <1% 2,826 $28K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,149 $28K
83735 <1% 3,694 $27K
72125 Computed tomography, cervical spine; without contrast material <1% 147 $26K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 628 $26K
87077 <1% 3,376 $24K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 7,483 $24K
97750 <1% 392 $23K
87040 <1% 1,182 $22K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,290 $22K
0637 <1% 14,545 $21K
97802 <1% 968 $21K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,578 $21K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,773 $21K
99204 Doctor's office visit, new patient (more involved) <1% 246 $21K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 454 $20K
99173 <1% 4,977 $20K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,693 $20K
73130 <1% 713 $20K
82043 <1% 2,258 $19K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 115 $18K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,697 $18K
83605 <1% 1,334 $17K
73110 <1% 561 $17K
72100 <1% 553 $17K
84703 <1% 2,108 $16K
84439 <1% 1,310 $16K
99284 Emergency room visit (serious) <1% 209 $14K
82570 <1% 2,359 $14K
82948 <1% 2,776 $14K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 281 $13K
86703 <1% 628 $13K
82607 <1% 646 $12K
0272 <1% 1,275 $12K
A0433 Advanced life support, level 2 (als 2) <1% 60 $12K
Z7610 <1% 1,527 $12K
99401 <1% 787 $12K
97010 <1% 705 $11K
85379 <1% 874 $10K
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) <1% 94 $10K
85027 <1% 1,401 $10K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 440 $9K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 601 $9K
76770 <1% 140 $9K
80048 Basic metabolic panel (calcium, ionized) <1% 1,066 $9K
84145 <1% 373 $9K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 752 $9K
72040 <1% 299 $9K
90670 <1% 1,673 $8K
84702 <1% 591 $8K
86140 <1% 1,089 $8K
77065 Tomosynthesis, mammo <1% 80 $7K
96156 <1% 505 $7K
90648 <1% 1,188 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 95 $6K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 456 $6K
73140 <1% 249 $6K
87070 <1% 673 $6K
93971 <1% 62 $6K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 321 $6K
J2060 Injection, lorazepam, 2 mg <1% 958 $6K
94664 <1% 401 $6K
96367 <1% 118 $5K
0250 <1% 1,127 $5K
71020 <1% 171 $5K
74019 <1% 174 $5K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 838 $5K
76536 <1% 89 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 772 $4K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 105 $4K
J2704 Injection, propofol, 10 mg <1% 1,354 $4K
90649 <1% 785 $4K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 39 $4K
80074 <1% 110 $4K
90723 <1% 706 $4K
90633 <1% 874 $4K
71101 <1% 113 $3K
S0164 Injection, pantoprazole sodium, 40 mg <1% 287 $3K
70486 <1% 24 $3K
82274 <1% 254 $3K
73502 <1% 97 $3K
0710 <1% 114 $3K
36415 Collection of venous blood by venipuncture <1% 3,989 $3K
92228 <1% 95 $3K
96368 <1% 110 $3K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 48 $3K
H1003 Prenatal care, at-risk enhanced service; education <1% 70 $3K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 26 $3K
85007 <1% 837 $3K
73080 <1% 96 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 884 $2K
72050 <1% 67 $2K
86592 <1% 509 $2K
82550 <1% 282 $2K
90791 Psychiatric diagnostic evaluation <1% 17 $2K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 164 $2K
90680 <1% 422 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 741 $2K
77066 Tomosynthesis, mammo <1% 14 $2K
86803 <1% 353 $2K
59430 <1% 25 $2K
74018 <1% 92 $2K
90710 <1% 384 $2K
90472 Immunization administration, each additional vaccine (list separately) <1% 108 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 198 $2K
83540 <1% 186 $1K
84153 <1% 96 $1K
82728 <1% 123 $1K
90834 Psychotherapy session, about 45 minutes <1% 20 $1K
90696 <1% 321 $1K
85652 <1% 418 $1K
99384 <1% 17 $1K
97162 <1% 27 $1K
87490 <1% 66 $1K
83550 <1% 113 $1K
90734 <1% 188 $1K
87590 <1% 77 $1K
86901 <1% 260 $1K
90716 <1% 212 $948.03
71010 <1% 53 $947.11
90707 <1% 185 $923.70
87340 <1% 148 $912.26
86900 <1% 259 $849.62
0324 <1% 15 $846.89
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 115 $841.76
86709 <1% 122 $830.58
86705 <1% 111 $777.96
29125 <1% 41 $713.10
90697 <1% 162 $691.14
80143 <1% 40 $675.36
80179 <1% 40 $675.36
29540 <1% 95 $666.12
87210 <1% 162 $635.25
97014 <1% 33 $632.94
87535 <1% 23 $623.51
90700 <1% 169 $573.76
0301 <1% 20 $496.06
92567 <1% 72 $492.31
80055 <1% 12 $479.49
86235 <1% 12 $394.11
85018 <1% 176 $391.45
87205 <1% 109 $391.10
99188 <1% 16 $356.40
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 26 $272.34
86580 <1% 68 $269.17
J0780 Injection, prochlorperazine, up to 10 mg <1% 31 $260.61
73590 <1% 12 $231.33
S0077 Injection, clindamycin phosphate, 300 mg <1% 21 $219.24
85013 <1% 84 $185.64
82553 <1% 16 $162.83
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 13 $161.86
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 1,840 $141.90
83655 <1% 12 $127.06
86225 <1% 12 $125.91
82950 <1% 28 $121.65
A4550 Surgical trays <1% 394 $116.55
90620 <1% 12 $108.00
84100 <1% 26 $100.73
82746 <1% 15 $89.84
69210 <1% 13 $89.40
86038 <1% 12 $89.01
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 12 $71.04
84550 <1% 20 $61.60
86431 <1% 12 $61.42
81000 <1% 13 $33.54
90658 <1% 893 $3.23
0271 0% 13 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 0% 47 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCROSKREY, ANN (CHIEF FINANCIAL OFFICER)
Parent organizationOAK VALLEY HOSPITAL DISTRICT
Same official

Other billing entities under CROSKREY, ANN

Full network →
ProviderLocationPaid
Oak Valley Hospital DistrictOakdale, CA$20.56M
Oak Valley Hospital DistrictRiverbank, CA$8.21M
Oak Valley Hospital DistrictEscalon, CA$3.55M
Oak Valley Hospital DistrictWaterford, CA$3.51M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.